BRAF V600 Wild Type
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases (NCT03175432) | M.D. Anderson Cancer Center | 2017-06-15 |
Track BRAF V600 Wild Type automatically
Every clearance here is in the API, with alerts when new ones post.